Product correctly added to cart.

discount label
Fmoc-L-Lys(Alloc)-OH
View 3D

Biosynth logo

Fmoc-L-Lys(Alloc)-OH

CAS: 146982-27-6

Ref. 3D-FF16395

10g
168.00 €
25g
232.00 €
50g
364.00 €
100g
517.00 €
250g
924.00 €
Estimated delivery in United States, on Tuesday 21 Jan 2025

Product Information

Name:
Fmoc-L-Lys(Alloc)-OH
Synonyms:
  • (S)-6-(Allyloxycarbonylamino)-2-(Fmoc-amino)hexanoic acid
  • Fmoc-Lys(Aloc)-OH
  • Fmoc-Lys(Alloc)-OH
  • N~2~-[(9H-fluoren-9-ylmethoxy)carbonyl]-N~6~-[(prop-2-en-1-yloxy)carbonyl]-L-lysine
Description:

Fmoc-L-Lys(Alloc)-OH is a peptide that consists of an amino acid sequence that is a variant of the human insulin molecule. The peptide has been modified to incorporate a pegyl group, which increases the serum stability of this drug and prevents enzymatic degradation. This compound has been tested in vitro by binding to nuclear DNA and inhibiting receptor binding. Fmoc-L-Lys(Alloc)-OH has also shown anticancer effects in vivo with tumor xenografts and apoptosis protein expression in human serum, as well as an increase in serine protease activity.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
452.5 g/mol
Formula:
C25H28N2O6
Purity:
Min. 98 Area-%
Color/Form:
Powder
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FF16395 Fmoc-L-Lys(Alloc)-OH

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".